Table 2. Relationship between clinicopathological characteristics and UCA1 and PGM5-AS1 expression (n=188).
| Variable | Cases | UCA1 | P-value* | PGM5-AS1 | P-value* |
|---|---|---|---|---|---|
| Median with interquartile range | Median with interquartile range | ||||
| Age | |||||
| <60 | 65 | 2.789 (1.474–4.634) | 0.279 | 1.275 (0.785–1.840) | 0.684 |
| ≥60 | 123 | 3.639 (1.434–4.170) | 1.223 (0.780–1.778) | ||
| Gender | |||||
| Male | 106 | 2.594 (1.331–4.042) | 0.441 | 1.117 (0.731–1.778) | 0.662 |
| Female | 82 | 3.010 (1.566–4.580) | 1.324 (0.989–1.850) | ||
| Differentiation | |||||
| Well | 87 | 2.338 (1.425–3.925) | 0.208 | 1.218 (0.773–1.759) | 0.898 |
| Moderate+Poor | 101 | 2.819 (1.464–4.619) | 1.253 (0.803–1.840) | ||
| AJCC stage | |||||
| I + II | 128 | 2.639 (1.459–4.077) | 0.904 | 1.137 (0.776–1.600) | 0.064 |
| III + IV | 60 | 2.858 (1.444–4.402) | 1.532 (0.844–2.014) |
*P-values are based on unpaired samples t test.